Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

Breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...

Colorectal cancer screening increased 12% and breast cancer screening increased 7% between 2019 and 2023. Cervical cancer screening remained 14% below rates from 2019, neither increasing or decreasing ...

Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal ...

As part of the Ontario Cervical Screening Program, the province has announced it is going to use Human Papillomavirus (HPV) testing rather than Pap smear tests as a primary way to screen for cervical ...

After a long decline, cervical cancer rates are rising in rural counties, increasing a gap with urban counties, a new study ...

Cervical cancer deaths have dropped due to better screening, but fewer women are keeping up with tests. An AXA Health ...